You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Idiopathic Pulmonary Fibrosis

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pulmonary Disease, Chronic Obstructive, Idiopathic Pulmonary Fibrosis, Asthma Trial in Seoul (HiCardi+)

Recruiting
  • Pulmonary Disease, Chronic Obstructive
  • +2 more
  • HiCardi+
  • Seoul, Korea, Republic of
    Severance Hospital
May 8, 2023

Idiopathic Pulmonary Fibrosis Trial in Australia, New Zealand (Ifenprodil)

Completed
  • Idiopathic Pulmonary Fibrosis
  • Brookvale, New South Wales, Australia
  • +5 more
Jul 18, 2022

Idiopathic Pulmonary Fibrosis Trial in Paris (Cyclophosphamide, Placebo, Corticosteroid (prednisolone))

Completed
  • Idiopathic Pulmonary Fibrosis
  • Paris, France
    Hôpital Tenon
Jun 27, 2022

Idiopathic Pulmonary Fibrosis Trial in Charleston (DWN12088, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Charleston, South Carolina
    Daewoong Investigator site
Jul 25, 2022

Idiopathic Pulmonary Fibrosis Trial (Cudetaxestat (BLD-0409), Control: Matching Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Cudetaxestat (BLD-0409)
  • Control: Matching Placebo
  • (no location specified)
May 12, 2022

Acute Exacerbation of Idiopathic Pulmonary Fibrosis Trial in France (Methylprednisone/Prednisone, Placebo)

Not yet recruiting
  • Acute Exacerbation of Idiopathic Pulmonary Fibrosis
  • Angers, France
  • +28 more
Jan 11, 2023

Idiopathic Pulmonary Fibrosis (IPF) Trial (ANG-3070, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis (IPF)
  • (no location specified)
Jun 8, 2022

Idiopathic Pulmonary Fibrosis Trial in Beijing (AK3280, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Beijing, Beijing, China
    China-Japan Friendship Hospital
Jul 19, 2022

IPF Trial (AMB-05X, Placebo)

Not yet recruiting
  • IPF
  • AMB-05X
  • Placebo
  • (no location specified)
Jul 27, 2022

Dyspnea and Idiopathic Pulmonary Fibrosis

Recruiting
  • Pulmonary Fibrosis
    • Lille, France
      Hop Calmette Chu Lille
    Mar 28, 2022

    Idiopathic Pulmonary Fibrosis Trial (CHF10067 starting dose, CHF10067 intermediate dose, CHF10067 high dose)

    Not yet recruiting
    • Idiopathic Pulmonary Fibrosis
    • CHF10067 starting dose
    • +3 more
    • (no location specified)
    Aug 22, 2022

    Nintedanib in Indian Patients With Idiopathic Pulmonary Fibrosis

    Completed
    • Idiopathic Pulmonary Fibrosis
      • Chennai, India
      • +9 more
      Aug 22, 2022

      Trends in Quality of Life in Idiopathic Pulmonary Fibrosis Under

      Active, not recruiting
      • Idiopathic Pulmonary Fibrosis
      • Alexandroupoli, Greece
      • +9 more
      Aug 22, 2022

      Idiopathic Pulmonary Fibrosis Trial in Boston (PLN-74809, Placebo)

      Recruiting
      • Idiopathic Pulmonary Fibrosis
      • Boston, Massachusetts
        Massachusetts General Hospital
      Nov 14, 2022

      Idiopathic Pulmonary Fibrosis Trial in Zhengzhou (Jin-shui Huan-xian granule, Jin-shui Huan-xian granule )

      Recruiting
      • Idiopathic Pulmonary Fibrosis
      • Jin-shui Huan-xian granule
      • Jin-shui Huan-xian granule placebo
      • Zhengzhou, China
        the First Affiliated Hospital of Henan University of Chinese Med
      Aug 17, 2022

      Idiopathic Pulmonary Fibrosis Trial in Suzhou (9MW3811 Injection, Placebo)

      Not yet recruiting
      • Idiopathic Pulmonary Fibrosis
      • 9MW3811 Injection
      • Placebo
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Jun 12, 2023

      Idiopathic Pulmonary Fibrosis, Acute Fatal Form Trial in United States (Autoantibody Reductive Therapy, Treatment as Usual

      Recruiting
      • Idiopathic Pulmonary Fibrosis, Acute Fatal Form
      • Autoantibody Reductive Therapy
      • Treatment as Usual (TAU)
      • Birmingham, Alabama
      • +6 more
      Sep 5, 2022

      Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis Trial (Hyperpolarized Xe129)

      Withdrawn
      • Idiopathic Pulmonary Fibrosis
      • Hypersensitivity Pneumonitis
      • Hyperpolarized Xe129
      • (no location specified)
      Sep 6, 2022

      Health and Quality of Life Assessment Project for Caregivers of

      Completed
      • Idiopathic Pulmonary Fibrosis
      • Patient-caregiver Dyads
      • Caregiver Quality of Life Questionnaires
      • Patient Quality of Life Questionnaires
      • Dijon, France
        CHU Dijon Bourgogne
      Apr 14, 2022

      Idiopathic Pulmonary Fibrosis Trial in Kingston (Nitric Oxide, Medical air)

      Recruiting
      • Idiopathic Pulmonary Fibrosis
      • Nitric Oxide
      • Medical air
      • Kingston, Ontario, Canada
        Respiratory Investigation Unit, Kingston General Hospital
      Apr 21, 2022

      Inspiratory Effort and Respiratory Mechanics in Spontaneously

      Active, not recruiting
      • Idiopathic Pulmonary Fibrosis
        • (no location specified)
        Apr 5, 2022

        Inspiratory Effort Assessed Through Nasal Pressure Measurement

        Not yet recruiting
        • Fibrosis, Pulmonary
        • Nasal pressure assessment
        • (no location specified)
        Mar 25, 2022

        Changes in iOS in IPF

        Active, not recruiting
        • Idiopathic Pulmonary Fibrosis
          • London, Gb-lnd, United Kingdom
            Royal Brompton and Harefield hospitals
          May 4, 2022

          Pulmonary Fibrosis, Lung Cancer Trial in Boston ([68Ga]CBP8, PET Imaging)

          Recruiting
          • Pulmonary Fibrosis
          • Lung Cancer
          • Boston, Massachusetts
            Massachusetts General Hospital
          Jun 13, 2022

          Mechanisms of Familial Pulmonary Fibrosis

          Recruiting
          • Familial Pulmonary Fibrosis
          • +2 more
            • Nashville, Tennessee
              Vanderbilt University Medical Center
            Mar 29, 2022